Active Biotech AB (ACTI) — Financial Flexibility Index
Active Biotech AB (ACTI) has a Financial Flexibility Index of -0.58x as of September 2025. Free cash flow of Skr-7.20 Million (operating CF Skr-7.20 Million minus capex Skr0.00) represents -1% of total liabilities (Skr12.50 Million). Check ACTI strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Active Biotech AB Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Active Biotech AB across 23 annual periods. See Active Biotech AB (ACTI) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Active Biotech AB (2002–2024)
Year-by-year free cash flow to debt coverage for Active Biotech AB. For the full company profile including market capitalisation, see Active Biotech AB (ACTI) total market value.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.63x | Skr-40.40 Million | Skr-40.40 Million | Skr11.13 Million | ▼ -6.2% |
| 2023 | -3.42x | Skr-45.74 Million | Skr-45.74 Million | Skr13.38 Million | ▼ -3.3% |
| 2022 | -3.31x | Skr-54.60 Million | Skr-54.85 Million | Skr16.49 Million | ▲ +27.4% |
| 2021 | -4.56x | Skr-46.17 Million | Skr-46.17 Million | Skr10.13 Million | ▼ -42.1% |
| 2020 | -3.21x | Skr-32.22 Million | Skr-32.22 Million | Skr10.04 Million | ▼ -18.0% |
| 2019 | -2.72x | Skr-35.81 Million | Skr-35.81 Million | Skr13.17 Million | ▼ -1335.0% |
| 2018 | -0.19x | Skr-40.65 Million | Skr-40.65 Million | Skr214.52 Million | ▲ +7.7% |
| 2017 | -0.21x | Skr-46.45 Million | Skr-46.45 Million | Skr226.14 Million | ▲ +35.3% |
| 2016 | -0.32x | Skr-73.16 Million | Skr-73.16 Million | Skr230.32 Million | ▲ +60.8% |
| 2015 | -0.81x | Skr-217.89 Million | Skr-217.89 Million | Skr268.84 Million | ▲ +3.1% |
| 2014 | -0.84x | Skr-265.19 Million | Skr-267.09 Million | Skr317.21 Million | ▼ -196.4% |
| 2013 | -0.28x | Skr-102.20 Million | Skr-102.25 Million | Skr362.40 Million | ▲ +58.1% |
| 2012 | -0.67x | Skr-240.38 Million | Skr-240.40 Million | Skr356.82 Million | ▼ -417.1% |
| 2011 | -0.13x | Skr-46.44 Million | Skr-46.97 Million | Skr356.53 Million | ▲ +78.7% |
| 2010 | -0.61x | Skr-196.23 Million | Skr-196.32 Million | Skr321.34 Million | ▲ +15.8% |
| 2009 | -0.73x | Skr-224.70 Million | Skr-224.77 Million | Skr309.86 Million | ▼ -43.2% |
| 2008 | -0.51x | Skr-156.61 Million | Skr-159.46 Million | Skr309.34 Million | ▲ +18.6% |
| 2007 | -0.62x | Skr-186.61 Million | Skr-186.70 Million | Skr299.97 Million | ▼ -149.9% |
| 2006 | -0.25x | Skr-100.10 Million | Skr-100.13 Million | Skr402.04 Million | ▲ +48.0% |
| 2005 | -0.48x | Skr-187.28 Million | Skr-192.51 Million | Skr391.05 Million | ▲ +51.8% |
| 2004 | -0.99x | Skr-149.58 Million | Skr-149.65 Million | Skr150.59 Million | ▲ +80.8% |
| 2003 | -5.17x | Skr-288.76 Million | Skr-288.83 Million | Skr55.82 Million | ▼ -54.9% |
| 2002 | -3.34x | Skr-291.31 Million | Skr-291.71 Million | Skr87.24 Million | — |